Clinical Trials Browser

Phase 1 × Iodine-124 × 90 days × Clear all

NCT03647358 2026-04-14

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Phase 1 Recruiting

Thyroid Neoplasms